Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma
NCT01278940
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
Malignant Melanoma
Interventions
BIOLOGICAL:
Dendritic Cells (DC) malignant melanoma
PROCEDURE:
IL-2
Sponsor
Oslo University Hospital